months on gluten containing diet presented with symptoms suggestive of (CD) were evaluated clinically and serologically using IgA human recombinant tissue transglutaminase antibody. (IgA anti tTG2). Multiple duodenal biopsies were performed for every patient enrolled in this study. CD cases had been followed up 6 months after a gluten free diet (GFD) by weight measurement and the mentioned serological testing.
. It occurs in genetically predisposed individuals (2) and marked geographical variations do appear to exist (3) .
The prevalence of celiac disease in Tunisian schoolchildren, estimated to be about 1/157 which is close to the European prevalence (2) .
In Jordan the serological prevalence was estimated to be 1:124 in schoolchildren (4) , whereas the average annual incidence in Kuwait is 1:3000 (5) . To date no prevalence of celiac disease data were reported from Iraq. Symptoms can begin at any age when gluten-containing foods are given; typical symptoms include diarrhea, offensive stools, abdominal distention, decreased appetite, failure to thrive, and iron-deficiency anemia not responding to oral iron therapy, edema and short stature (1, 6, 7) . It is recommended that CD be an early consideration in the differential diagnosis of children with FTT and persistent diarrhea. Limited data suggest the prevalence of CD may be increased 2-10 times in children with some of these GI symptoms or occur in up to 5% of cases (8) .
Definitive diagnosis of celiac disease requires small intestinal biopsy (1) . According to the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), there is a recognized spectrum of histologic features varying from mild to severe as described by Marsh et al (8) . (8, 9) . Despite the increasing importance of serological methods, the diagnosis of CD is still based on histological criteria (8) (9) (10) followed by a therapeutic response to a gluten free diet (9) .
The mucosal involvement can be patchy, so multiple biopsies must be obtained (1) .
Given the lifelong nature of the disease, the attendant need for an expensive socially inconvenient gluten free diet (GFD) and the sporadic local practice of a trail of GFD without confirmations of CD diagnosis in spite of availability of CD serological screening tests leads the investigator to asses the value of clinical data in diagnosis and follow up of CD in relation to investigational tools. selected in the study were aged more than 6 months and on gluten containing diet, with various combinations of symptoms and signs suggestive of CD including chronic diarrhea, abdominal distention, offensive stool, anorexia, positive family history of CD in first degree relative, anemia defined according to C age and sex related hemoglobin levels and failure to thrive (FTT) defined as weight <5 th centile for age and sex. A total of 57 patients (39 males, 18 females) with mean age of 56.1 months, were evaluated by history and physical examination. They were screened by serological testing using second generation ELISAs IgA human recombinant tissue transglutaminase antibody (IgA anti tTG2) which was done by commercially available kit (AESKULISA tTG-A 3503/ Germany). Esophagogastroduedinoscopy and biopsy was done in Alsalam General Hospital in Mosul city where three sites of duodenum were biopsied from every patient. Biopsy specimens were evaluated in the same hospital and pathology reports were analyzed according to Marsh criteria (4) .
Patients and methods
Patients were reevaluated 6 months after GFD by weight measurements and same serological test.
Verbal consents were approved regarding clinical, hematological testing along with written informed consents were taken from parents of all children before endoscopic duodenal biopsy. The ethical committee approved this study.
Data analysis was done using SPSS program. Chi squared test was used for measurement of statistical significance. Clinical features of studied patients with positive biopsy of CD showed that FTT was noticeable in 25 (86.2%) of patients followed by anemia, abdominal distension, and offensive stool in decreasing frequency. In 17 patients (58.6 %) who had CD had chronic diarrhea (Table 2) .
Results
IgA anti-tTG2 test was above the cut-off value of the used kit for a positive result which is more than 15 U/ml in 29 
Discussion
In 29 (50.9%) of studied cases, the diagnosis was correct based on clinical data, the positive predictive values of the majority of selected variables ranged approximately between (44%-54%) as an indicative of celiac disease diagnosis based on clinical manifestation. These findings support the recommendations of (NASPGHAN) (8) , signifying the value of history and examination in selecting symptomatic patients for screening for CD. It has been estimated that the prevalence of celiac disease in children between 2.5 and 15 yr in the general population ranges from 3 to 13/1,000 children or ≈1/300 to 1/80 children (1) , screening of patients with symptoms of celiac disease resulted in increase detection of CD from 3-13/1,000 children in the general population to 50.9% according to this study. The diagnosis of celiac disease on the basis of clinical features alone was incorrect in 28(49.1 %) studied cases, similar results have been observed in other studies which showed that a clinical diagnosis in children on the basis of gastrointestinal symptoms alone was incorrect in more than 50% of cases (11) (12) , signifying that diagnosis and lifelong GFD treatment is not justifiable relying on clinical diagnosis alone. The male: female ratio of the children with CD was 3:2 in the study done by Ujjal et al (13) , which is similar to the present study results. Although the sensitivity of some variables (offensive stool, abdominal distention, FTT and anemia) was high (close or over 80%) their specificity was low (around 20%), furthermore the studied clinical variables were not significantly associated with biopsy results (pvalue >0.05), these may be explained by the fact that these clinical variables are common shared manifestations of other diseases that CD should be differentiated from (3) .
In (58.6%) of studied CD patients had chronic diarrhea, comparable results were present in other studies (14) (15) . In 41.4% of celiac cases in this study had normal bowel motion, Telega et al found that 28.2% of his cases had diarrhea and 5.1% had constipation suggesting that the remaining 66.7% had normal bowel motion (16) , indicating that normal bowel motion does not preclude the possibility of CD diagnosis. Offensive stool was the compliant of (75.9 %) of our celiac disease patients compared to 50% in other study (1) which might be related to the severity and extent of mucosal damage. Abdomen was distended in (79.3 %) of studied CD patients, similar results (80%) were found by Khuffash et al (5) . Anorexia presented in two thirds of our cases which are concordant with the finding in other studies (1, 17) .
Kuloğlu et al in Turkey observed failure to thrive in 34.8% of cases of CD (18) and Telega et al in Southeastern Wisconsin found that 25.4% of cases with CD presented with FTT (16) . While FTT was reported in 100% of cases with CD in Arabic studies conducted by AlHassany et al in Iraq (19) , Khuffash et al (5) in
Kuwait and Al-Tawaty et al in Libya (20) , FTT reported in 91% of CD patients in India (21) . In our study (86.2%) of CD cases present with FTT. This high frequency of FTT may be attributed to delayed diagnosis, severity of mucosal damage with malabsorptive consequences or concomitant malnutrition. Less common presentations of celiac disease include hypoproteinemia (22) , secondary to protein-losing enteropathy (7) manifested by edema which was evident in 3.4 % of studied patients. Rashid et al found that 8% of the children had a first-degree relative with biopsyconfirmed celiac disease (23) , while family history was positive in 21% in the study conducted by D'Amico et al in USA (24) . In our study positive family history was found in (13.8%) of cases, similar result was found by Barker et al (7) . This difference may be attributed to the heterogeneity of the studied populations, subject selection, different genetic susceptibility and rate of consanguineous marriages. Positive family history was the positive predictor of CD diagnosis in 66.7% of cases before the diagnosis was histologicaly confirmed, having specificity of 92.8%. The result found in our study supports the routine testing of asymptomatic children who are firstdegree relatives of confirmed celiac disease recommended by (NASPGHAN). Anemia is still a common presentation of celiac disease (25) . Hypochromic microcytic morphology was the most frequent type associated with CD cases in this study , which is concordant with the finding in other studies (14, 16, 17) . In 43.9% of cases in this study hypochromic microcytic anemia was among the presenting findings leading to the diagnosis of celiac disease, similar result was found in Greek by Karyda et al (26) and in
Basrah by Mansoor et al (27) . Whereas higher results were found by Hashim et al (28) , this may be related to the sample selection and time of diagnosis. Overall all these results support the recommendations of (NASPGHAN) that persistent iron deficiency anemia is an indication for celiac screening (4) .
Dimorphic anemia was present in 20.7% of studied cases with celiac disease and Patwari et al also found that 20% of CD had dimorphic anemia (29) nevertheless it was the foreteller of the diagnosis in 85.7% of studied cases as a positive predictor of CD before biopsy results appeared and having a specificity of 96.4%. These high values may be related to the severity of mucosal injury in view of the fact that all studied patients with dimorphic anemia had Marsh 3 histopathological grading. Overall, the severity of symptoms associated with celiac disease is highly variable, and in large part this reflects the severity and extent of mucosal damage (3) , which explain the more frequent symptoms in our patients with Marsh 3 histopathological changes. The reported prevalence of GI manifestations has varied widely among different studies; this may be due to the low number of patients evaluated or a delay in their presentation (30) .
Catch-up growth is characterized by an increased growth velocity in height and/or weight after the removal of some constraint on normal growth, this increased velocity brings a child's height-for-age or weight-for-age status back toward the normal centiles (31) . Treatment with GFD did not result in an overall significant increase in weight-for-height score up to 4 years of follow-up (32) . Mean weight-for-height returned to normal 15 months after dietary treatment (33) . Failure of the anti-tTG level to decline over a period of 6 months after starting the GFD suggests continued ingestion of gluten or related products (4) . Catch up of weight was not achieved in 10 (43.5%) out of 23 enrolled CD patients with FTT whose (IgA anti tTG2) normalized after 6 months of GFD, indicating that catch up of weight may be delayed, cannot be relied upon as an early marker of clinical improvement in patients with proven adherence to GFD manifested by normal serological monitoring as well as in patients on trail of GFD without disease confirmation. The result of this study albeit reflecting private clinic statistics, evidently illustrated that celiac disease manifestations is a useful tool to initiate an effective serological screening tests rather than a tool to label a diagnosis and permanently treat assumed celiac disease without based evidence ,along with erroneous follow up of manifestation rather than the disease. As in no case should false information given to the patient, this study notify a doctor about percentages of incorrect decisions made depending only on clinical experience of CD, which ultimately affect patient health in addition to its impact on social, financial and psychological aspects of patient life and also reflects the ethical and medical responsibility of the doctor toward his patient aiming to give optimum quality of available medical care. The result of this study emphasizes the importance of the patient human rights to get an evidently based accurate diagnosis of celiac disease before permanent changing of dietary life style.
